Demonstrating the utility of CP in cervicalcancer screening, Rungkamoltipet al. (2023) identified distinct peptide patterns between healthywomen and those with cervical cancer through MALDI-TOF-MS analysis.These differences in peptide profiles indicate that certain mass-to-chargeratio peaks could serve as potential biomarkers for the early detectionof cervical cancer.76 The gene discussed is CP; the disease is cervical carcinoma.